参麦注射液治疗原发性干燥综合征的疗效观察  

Clinical Observation of Shenmai Injection in Treatment of Primary Sjogren Syndrome

作　　者：黄晓娟[1] 徐桂华[1] 李连茂[1] 崔恩臣[1] 

机构地区：[1]哈尔滨242医院中医科,哈尔滨市150060

出　　处：《中国药房》2010年第8期724-725,共2页China Pharmacy

摘　　要：目的:观察参麦注射液治疗原发性干燥综合征的临床疗效。方法:将61例患者随机分为2组,对照组29例,应用环戊硫酮片治疗;治疗组32例,在对照组的基础上加用参麦注射液治疗。15d为1个疗程,比较2组的疗效及不良反应。结果:对照组有效率68.96%,有3例出现腹部不适、腹泻;治疗组有效率90.63%,无严重不良反应;2组有效率比较差异有统计学意义(P<0.05)。结论:参麦注射液治疗原发性干燥综合征疗效显著,且不良反应少。OBJECTIVE： To observe the clinical effect of Shenmai injection for primary sjogren syndrome. METHODS： 61 patients were randomized to receive anethole trithione （control group, n：29） or anethole trithione and Shenmai injection （treatment group, n：32） respectively with 15 days as a course of treatment. RESULTS： The total effective rate was 68.96% for control group and 90.63% for treatment group. There were 3 cases of abdominal discomfort ordiarrhea in control group, and no serious ADR was detected in treatment group. Significant difference was noted between two groups （P〈0.05）. CONCLUSION： Shenmai injection shows good curative effect in treatment of primary sjogren syndrome and little side effect.

关 键 词：参麦注射液 环戊硫酮片 原发性干燥综合征 

分 类 号：R593.31[医药卫生—内科学]